Prestige Consumer Healthcare Inc. (PBH) financial statements and ratios from SEC XBRL: revenue $1.1B (TTM), net margin 17.5%, revenue growth 6.5% YoY, P/E 14.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.09B |
| Revenue (TTM) | $1.1B |
| Net Margin | 17.5% |
| Operating Margin (TTM) | 26.3% |
| Net Debt / EBITDA | 6.0 |
| Revenue Growth (YoY) | 6.5% |
| EPS Growth (YoY) | -36.5% |
| FCF Growth (YoY) | -14.2% |
| P/E Ratio | 14.1 |
| EV / EBITDA | 13.5 |
| Price / Book | 1.27 |
| Price / Sales | 2.20 |
| FCF Yield | 9.7% |
| Altman Z-Score | 2.32 (grey) |
| Piotroski F-Score | 5/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
PBH overview · PBH earnings · PBH KPIs · PBH documents · PBH ownership · PBH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.